Integer (NYSE:ITGR) Hits New 52-Week High – Still a Buy?

Shares of Integer Holdings Corporation (NYSE:ITGR) hit a new 52-week high during trading on Friday . The stock traded as high as $126.25 and last traded at $126.2050, with a volume of 152264 shares. The stock had previously closed at $125.50.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of research analyst reports. HC Wainwright reaffirmed a “buy” rating on shares of Integer in a report on Friday, July 24th. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Wells Fargo & Company raised their price objective on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 4th. KeyCorp downgraded shares of Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday, August 3rd. Finally, Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $109.86.

Integer Trading Up 0.7%

The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. The company has a market capitalization of $4.30 billion, a price-to-earnings ratio of 34.52, a P/E/G ratio of 2.36 and a beta of 0.62. The business’s 50-day simple moving average is $110.33 and its 200-day simple moving average is $95.65.

Integer (NYSE:ITGR) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.55 EPS. On average, research analysts expect that Integer Holdings Corporation will post 6.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Integer

Hedge funds and other institutional investors have recently bought and sold shares of the business. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of Integer during the 2nd quarter valued at $29,000. EverSource Wealth Advisors LLC boosted its position in shares of Integer by 48.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares during the last quarter. Harbor Investment Advisory LLC bought a new position in shares of Integer in the 2nd quarter worth $42,000. TD Private Client Wealth LLC grew its stake in shares of Integer by 1,037.5% during the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 415 shares during the period. Finally, Parkside Financial Bank & Trust grew its stake in shares of Integer by 135.5% during the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 267 shares during the period. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.